Hayat Pharmaceutical Industries Co. PLC

ASE-HPIC
Amman Stock Exchange
Pharmaceutical Preparations
Global Rank
#32051
Country Rank
#53
Market Cap
44.95 M
Price
4.73
Change (%)
1.52%
Volume
100

Hayat Pharmaceutical Industries Co. PLC's latest marketcap:

44.95 M

As of 04/30/2026, Hayat Pharmaceutical Industries Co. PLC's market capitalization has reached $44.95 M. According to our data, Hayat Pharmaceutical Industries Co. PLC is the 32051th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 44.95 M
Revenue (ttm) 24.16 M
Net Income (ttm) 3.26 M
Shares Out 9.5 M
EPS (ttm) 0.34
Forward PE 0.00
Ex-Dividend Date 04/16/2026
Earnings Date 03/19/2026
Market Cap Chart
Data Updated: 04/30/2026

Hayat Pharmaceutical Industries Co. PLC's yearly market capitalization.

Hayat Pharmaceutical Industries Co. PLC has seen its market value grow from د.أ21.76 M to د.أ30.97 M since 2014, representing a total increase of 42.36% and an annual compound growth rate (CAGR) of 3.15%.
Date Market Cap(د.أ) Market Cap(USD) Change (%) Global Rank
05/18/2026 د.أ30.97 M $43.74 M -1.21% n/a
12/31/2025 د.أ31.35 M $44.28 M 34.69% 30462
12/31/2024 د.أ23.28 M $32.79 M 2.08% 30890
12/31/2023 د.أ22.8 M $32.13 M -18.64% 30727
12/29/2022 د.أ28.02 M $39.43 M -22.16% 28499
12/30/2021 د.أ36 M $50.78 M 56.61% 27438
12/31/2020 د.أ22.99 M $0 23.47% 27110
12/31/2019 د.أ18.62 M $26.23 M 1.55% 25207
12/31/2018 د.أ18.34 M $25.82 M -4.93% 24333
12/31/2017 د.أ19.28 M $27.07 M 5.73% 24371

Company Profile

About Hayat Pharmaceutical Industries Co. PLC

Hayat Pharmaceutical Industries Co. PLC is a Jordan-based company specializing in the manufacturing and marketing of generic pharmaceutical products. Established in 1994 and headquartered in Amman, the company serves diverse therapeutic segments with high-quality medications.

Key Offerings

Hayat Pharmaceutical provides a wide range of pharmaceutical products across multiple therapeutic areas, including:

  • Allergies
  • Cardiovascular system
  • Dermatology
  • Gastrointestinal system
  • Infectious diseases
  • Inner ear and balance
  • Neurology
  • Pain and inflammation management
  • Respiratory system
  • Vitamins and supplements
  • Men’s and women’s health products

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Research Tools

Copyright © 2026. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.